Dr. Stephanie G. Van Decker, MD

Dr. Van Decker practices at Penn Presbyterian Medical Center in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Van Decker's NPI, 1588168967, was assigned on March 21, 2018. Dr. Van Decker graduated from Temple University School of Medicine in 2018. Dr. Van Decker holds Pennsylvania license MD483813.

Dr. Van Decker's primary practice is Penn Presbyterian Medical Center, at 51 North 39th Street, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-8000.

Dr. Van Decker's primary practice is Penn Presbyterian Medical Center in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Van Decker is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Van Decker to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Van Decker practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Van Decker's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Van Decker is licensed in Pennsylvania.

CMS data shows 88 Medicare services from Dr. Van Decker across 4 procedure codes in 2024, for 56 Medicare patients. Medicare paid $10,501 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 56 Medicare patients who saw Dr. Van Decker in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Van Decker's median patient age at 62, with 56% women.

In 2024, Dr. Van Decker wrote 179 Medicare Part D claims for 42 patients. 52% of them were for generic drugs. CMS names the drug for 94 of them, across 5 drugs with 11 or more claims each, at $17,938 in total drug cost. In 2023, CMS named 56 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Van Decker for performance year 2024, reported as part of a group. Dr. Van Decker accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Van Decker as offering telehealth.

Dmand AI links 2 papers to Dr. Van Decker in 2012. Dr. Van Decker's most frequent co-authors are Nicholas Andrew Bosch, MD, Angela R. Bradbury, MD and Paula Karen Rauch, MD.

Dr. Van Decker graduated from Temple University School of Medicine in 2018.